title: Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients.
abstract: OBJECTIVE
  The aim of this study was to evaluate the incidence of early thrombosis, its prognostic significance, and the therapeutic implications.
  
  
  BACKGROUND
  Transesophageal echocardiography (TEE) is the method of choice for detecting symptomless early postoperative thrombosis of prosthetic valves. However, the clinical significance is not yet known.
  
  
  METHODS
  Between June 1994 and December 2000, 680 consecutive patients underwent TEE on day 9 after mechanical mitral valve replacement, to search for early thrombosis. Initially, end points were the in-hospital outcome and treatment. Patients were also evaluated 34 +/- 22 months after surgery.
  
  
  RESULTS
  Sixty-four early thrombi were detected (9.4%). Two early obstructive were treated by redo-surgery. Sixty-two nonobstructive benefited from medical treatment. The patients were allocated into two groups as a function of the maximum size of thrombus: <5 mm in 29 patients (group A) and > or =5 mm in 35 (group B). During early follow-up, we observed one complicated course in group A and eight in group B. In the long-term survey, three complications were noted in group A and 11 in group B. Incidence of early (p = 0.027) and long-term (p = 0.04) complications were significantly different in the two subsets.
  
  
  CONCLUSIONS
  This study confirms the incidence of early thrombi after mechanical mitral valve replacement detected by TEE. A small (<5 mm) nonobstructive thrombus seems benign, and our experience argues in favor of medical treatment. Prognosis appears more serious for large thrombi. Medically aggressive therapy and further surgery should be considered in cases of obstructive thrombosis or large and mobile nonobstructive thrombosis.
authors.affiliation: Service de Cardiologie, Hôpital Cardiologique du Haut-Lévêque, Chu de Bordeaux, Pessac, France. raymond.roudaut@pu.u-bordeaux2.fr
authors.forename: Guillaume
authors.initials: G
authors.lastname: Laplace
authors.forename: Stéphane
authors.initials: S
authors.lastname: Lafitte
authors.forename: Jean-Noèl
authors.initials: JN
authors.lastname: Labèque
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Perron
authors.forename: Eugène
authors.initials: E
authors.lastname: Baudet
authors.forename: Claude
authors.initials: C
authors.lastname: Deville
authors.forename: Xavier
authors.initials: X
authors.lastname: Roques
authors.forename: Raymond
authors.initials: R
authors.lastname: Roudaut
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004452:Echocardiography; D017548:Echocardiography, Transesophageal; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006331:Heart Diseases / Q000000981:diagnostic imaging / Q000209:etiology*; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000000981:diagnostic imaging / Q000601:surgery*; D011183:Postoperative Complications / Q000000981:diagnostic imaging / Q000209:etiology*; D011446:Prospective Studies; D011474:Prosthesis Design; D013927:Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology*; D013995:Time; D013997:Time Factors; D016896:Treatment Outcome